AAOpt 2022: A collaborative approach to pediatric keratoconus offers positive patient outcomes

Article

Christina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.

A collaborative approach to pediatric keratoconus offers positive patient outcomes.

A collaborative approach to pediatric keratoconus offers positive patient outcomes.

Christina Twardowski, OD, FAAO, program director for the Children's Mercy Pediatric Optometry Residency Program as well as clinical assistant professor of ophthalmology at the University of Missouri-Kansas City School of Medicine.

Christina Twardowski, OD, FAAO

Erin D. Stahl, MD is a pediatric ophthalmologist who serves as the Division Director of Ophthalmology and the Associate Chair of Surgery at Children's Mercy Kansas City.  She is a Professor in the Department of Ophthalmology at the University of Missouri - Kansas City School of Medicine.

Erin D. Stahl, MD

The 2022 American Academy of Optometry meeting is taking place this year in San Diego. Drs. Christina Twardowski and Erin Stahl share with Optometry Times® key highlights from their discussion, "A collaborative approach to pediatric keratoconus," which they presented during the meeting.

Christina Twardowski, OD, FAAO, is program director for the Children's Mercy Pediatric Optometry Residency Program, as well as clinical assistant professor of ophthalmology at the University of Missouri-Kansas City School of Medicine, and Erin D. Stahl, MD, a pediatric ophthalmologist who serves as the Division Director of Ophthalmology and the Associate Chair of Surgery at Children's Mercy Kansas City, as well as professor in the Department of Ophthalmology at the University of Missouri - Kansas City School of Medicine.

What are the key takeaways from the presentation?

  1. There is no bad referral - Many times, doctors believe they should hold onto a patient until a diagnosis can be confirmed. Pediatric keratoconus can progress rapidly which means waiting for certainty on the diagnosis can result in permanent vision loss. Any suspicion for keratoconus warrants a referral. 
  2. Use your retinoscope - Doctors often attempt secondary testing to help confirm the diagnosis of keratoconus. When dealing with children, testing attempts are frequently unsuccessful secondary to patient cooperation. Retinoscopy is a tool we all have and can confirm the diagnosis of keratoconus on any aged patient. 
  3. Optical treatment AND medical treatment are required - Being able to provide your pediatric keratoconus patients with both treatments is imperative for a successful vision and ocular health outcome. Collaboration between optometry and ophthalmology is key in meeting the expectations of the family and providing long-term vision success.

Why is this so important for optometrists to address?

Optometrists tend to be the first at seeing and diagnosing keratoconus patients. Pediatric keratoconus may not be a diagnosis that comes into your office every week but understanding the severity of condition and the required treatment that is needed for these patients will help guide your decisions for the future.

What does this mean for patient care?

Early detection and treatment are paramount to avoid serious visual impairment. Corneal cross-linking offers a true treatment for keratoconus, halting the corneal changes and avoiding the gamut of visual rehabilitation options. Pediatric patients with keratoconus require early diagnosis, careful examination, and early intervention by CXL to ensure a positive visual prognosis.

Recent Videos
Bonnie An Henderson in an interview for the EnVision Summit
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
© 2024 MJH Life Sciences

All rights reserved.